Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cytokinetics Inc (CYTK) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Cytokinetics Inc. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1061983.
Total stock buying since 2015: $3,409,639.
Total stock sales since 2015: $141,802,280.
Total stock option exercises since 2015: $22,061,108.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 301,628 | $12,455,598 | 87,000 | $1,012,460 |
| 2024 | 0 | $0 | 566,913 | $33,770,931 | 441,385 | $3,574,553 |
| 2023 | 0 | $0 | 336,003 | $12,584,418 | 302,540 | $2,503,702 |
| 2022 | 0 | $0 | 602,547 | $26,510,660 | 622,168 | $5,834,212 |
| 2021 | 0 | $0 | 481,309 | $16,423,971 | 491,287 | $4,201,854 |
| 2020 | 0 | $0 | 1,947,945 | $35,408,116 | 442,810 | $3,361,709 |
| 2019 | 348,072 | $3,280,519 | 64,000 | $656,817 | 0 | $0 |
| 2018 | 0 | $0 | 50,709 | $406,852 | 2,709 | $17,798 |
| 2017 | 0 | $0 | 229,802 | $3,344,442 | 182,703 | $1,417,008 |
| 2016 | 0 | $0 | 5,633 | $69,632 | 0 | $0 |
| 2015 | 21,000 | $129,120 | 21,875 | $170,843 | 21,875 | $137,812 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-07-08 | Smith Sandford D (Director) | Option Ex | 1,434 | 6.21 | 8,905 |
| 2020-07-07 | Smith Sandford D (Director) | Sale | 11,742 | 26.50 | 311,163 |
| 2020-07-07 | Smith Sandford D (Director) | Option Ex | 11,742 | 6.46 | 75,912 |
| 2020-07-06 | Blum Robert I (President & CEO) | Sale | 5,000 | 24.85 | 124,255 |
| 2020-07-06 | Blum Robert I (President & CEO) | Option Ex | 5,000 | 6.00 | 30,000 |
| 2020-06-24 | Blum Robert I (President & CEO) | Sale | 5,000 | 23.86 | 119,309 |
| 2020-06-24 | Blum Robert I (President & CEO) | Option Ex | 5,000 | 6.15 | 30,750 |
| 2020-06-22 | Smith Sandford D (Director) | Sale | 10,000 | 24.50 | 245,000 |
| 2020-06-22 | Smith Sandford D (Director) | Option Ex | 10,000 | 4.44 | 44,400 |
| 2020-06-22 | Parshall B Lynne (Director) | Sale | 16,510 | 25.00 | 412,750 |
| 2020-06-22 | Parshall B Lynne (Director) | Option Ex | 16,510 | 5.58 | 92,125 |
| 2020-06-22 | Costa Santo J (Director) | Sale | 20,000 | 25.00 | 500,000 |
| 2020-06-22 | Costa Santo J (Director) | Option Ex | 20,000 | 7.61 | 152,200 |
| 2020-06-17 | Smith Sandford D (Director) | Sale | 6,907 | 23.00 | 158,861 |
| 2020-06-17 | Smith Sandford D (Director) | Option Ex | 6,907 | 6.81 | 47,036 |
| 2020-06-15 | Smith Sandford D (Director) | Sale | 6,666 | 22.00 | 146,652 |
| 2020-06-15 | Smith Sandford D (Director) | Option Ex | 6,666 | 6.30 | 41,995 |
| 2020-06-12 | Smith Sandford D (Director) | Sale | 15,045 | 20.94 | 314,997 |
| 2020-06-12 | Smith Sandford D (Director) | Option Ex | 15,045 | 4.74 | 71,313 |
| 2020-06-11 | Blum Robert I (President & CEO) | Sale | 5,000 | 21.47 | 107,355 |
| 2020-06-11 | Blum Robert I (President & CEO) | Option Ex | 5,000 | 6.30 | 31,500 |
| 2020-05-29 | Blum Robert I (President & CEO) | Sale | 5,000 | 20.10 | 100,505 |
| 2020-05-29 | Blum Robert I (President & CEO) | Option Ex | 5,000 | 6.30 | 31,500 |
| 2020-05-19 | Henderson John T (Director) | Option Ex | 3,333 | 16.86 | 56,194 |
| 2020-05-18 | Blum Robert I (President & CEO) | Sale | 5,000 | 22.13 | 110,640 |
| 2020-05-18 | Blum Robert I (President & CEO) | Option Ex | 4,189 | 6.30 | 26,390 |
| 2020-05-18 | Gage L Patrick (Director) | Option Ex | 3,333 | 16.86 | 56,194 |
| 2020-05-11 | Costa Santo J (Director) | Sale | 29,999 | 19.65 | 589,390 |
| 2020-05-11 | Costa Santo J (Director) | Option Ex | 29,999 | 10.03 | 300,889 |
| 2020-05-05 | Costa Santo J (Director) | Sale | 8,332 | 17.00 | 141,644 |
| 2020-05-05 | Costa Santo J (Director) | Option Ex | 8,332 | 6.12 | 50,991 |
| 2020-05-01 | Blum Robert I (President & CEO) | Sale | 5,000 | 14.34 | 71,680 |
| 2020-04-28 | Wierenga Wendall (Director) | Sale | 9,999 | 16.00 | 159,984 |
| 2020-04-28 | Wierenga Wendall (Director) | Option Ex | 9,999 | 9.84 | 98,390 |
| 2020-03-06 | Gage L Patrick (Director) | Sale | 8,000 | 14.82 | 118,592 |
| 2020-02-13 | Lampert Mark N | Sale | 1,072,030 | 15.79 | 16,924,137 |
| 2020-01-15 | Blum Robert I (President & CEO) | Sale | 4,950 | 12.96 | 64,156 |
| 2019-12-16 | Blum Robert I (President & CEO) | Sale | 6,000 | 10.22 | 61,326 |
| 2019-12-11 | Lampert Mark N | Buy | 118,413 | 9.52 | 1,126,699 |
| 2019-12-10 | Lampert Mark N | Buy | 223,659 | 9.40 | 2,102,394 |
| 2019-12-05 | Malik Fady Ibraham (EVP Research & Development) | Sale | 1,500 | 9.80 | 14,700 |
| 2019-11-19 | Henderson John T (Director) | Buy | 6,000 | 8.57 | 51,426 |
| 2019-11-15 | Blum Robert I (President & CEO) | Sale | 6,000 | 8.09 | 48,510 |
| 2019-11-07 | Malik Fady Ibraham (EVP Research & Development) | Sale | 1,500 | 9.98 | 14,970 |
| 2019-10-15 | Blum Robert I (President & CEO) | Sale | 6,000 | 11.16 | 66,978 |
| 2019-10-03 | Malik Fady Ibraham (EVP Research & Development) | Sale | 1,500 | 11.22 | 16,830 |
| 2019-09-16 | Blum Robert I (President & CEO) | Sale | 6,000 | 12.74 | 76,470 |
| 2019-09-05 | Malik Fady Ibraham (EVP Research & Development) | Sale | 1,500 | 13.69 | 20,532 |
| 2019-08-15 | Blum Robert I (President & CEO) | Sale | 6,000 | 12.64 | 75,816 |
| 2019-08-08 | Malik Fady Ibraham (EVP Research & Development) | Sale | 1,500 | 13.52 | 20,280 |
| 2019-07-15 | Blum Robert I (President & CEO) | Sale | 6,000 | 10.94 | 65,634 |
| 2019-07-11 | Malik Fady Ibraham (EVP Research & Development) | Sale | 1,500 | 11.26 | 16,890 |
| 2019-06-17 | Blum Robert I (President & CEO) | Sale | 6,000 | 9.71 | 58,236 |
| 2019-06-06 | Malik Fady Ibraham (EVP Research & Development) | Sale | 1,500 | 10.31 | 15,463 |
| 2019-05-02 | Malik Fady Ibraham (EVP Research & Development) | Sale | 1,500 | 8.29 | 12,430 |
| 2019-04-04 | Malik Fady Ibraham (EVP Research & Development) | Sale | 1,500 | 8.31 | 12,465 |
| 2019-03-07 | Malik Fady Ibraham (EVP Research & Development) | Sale | 1,500 | 5.98 | 8,970 |
| 2019-02-07 | Malik Fady Ibraham (EVP Research & Development) | Sale | 1,500 | 7.28 | 10,920 |
| 2019-01-10 | Malik Fady Ibraham (EVP Research & Development) | Sale | 1,500 | 7.31 | 10,965 |
| 2019-01-04 | Blum Robert I (President & CEO) | Sale | 4,000 | 7.11 | 28,432 |
| 2018-12-06 | Malik Fady Ibraham (EVP Research & Development) | Sale | 1,500 | 7.38 | 11,070 |
| 2018-12-06 | Blum Robert I (President & CEO) | Sale | 4,000 | 7.50 | 29,988 |
| 2018-11-05 | Blum Robert I (President & CEO) | Sale | 4,000 | 7.11 | 28,448 |
| 2018-11-01 | Malik Fady Ibraham (EVP Research & Development) | Sale | 1,500 | 6.68 | 10,020 |
| 2018-10-05 | Blum Robert I (President & CEO) | Sale | 4,000 | 8.79 | 35,180 |
| 2018-10-04 | Malik Fady Ibraham (EVP Research & Development) | Sale | 1,500 | 9.14 | 13,710 |
| 2018-09-06 | Malik Fady Ibraham (EVP Research & Development) | Sale | 1,500 | 8.00 | 12,000 |
| 2018-09-05 | Blum Robert I (President & CEO) | Sale | 4,000 | 7.94 | 31,768 |
| 2018-08-03 | Blum Robert I (President & CEO) | Sale | 4,000 | 6.65 | 26,584 |
| 2018-08-02 | Malik Fady Ibraham (EVP Research & Development) | Sale | 1,500 | 6.85 | 10,275 |
| 2018-07-05 | Malik Fady Ibraham (EVP Research & Development) | Sale | 1,500 | 9.05 | 13,575 |
| 2018-07-05 | Blum Robert I (President & CEO) | Sale | 4,000 | 9.09 | 36,372 |
| 2018-06-07 | Malik Fady Ibraham (EVP Research & Development) | Sale | 3,000 | 8.95 | 26,849 |
| 2018-06-05 | Blum Robert I (President & CEO) | Sale | 4,000 | 8.28 | 33,116 |
| 2018-05-04 | Blum Robert I (President & CEO) | Sale | 4,000 | 8.36 | 33,424 |
| 2018-04-05 | Blum Robert I (President & CEO) | Sale | 4,000 | 7.52 | 30,092 |
| 2018-01-16 | Mcdowell Caryn Gordon (GC & Chief Compliance Officer) | Sale | 2,709 | 9.00 | 24,381 |
| 2018-01-16 | Mcdowell Caryn Gordon (GC & Chief Compliance Officer) | Option Ex | 2,709 | 6.57 | 17,798 |
| 2017-11-02 | Mcdowell Caryn Gordon (GC & Chief Compliance Officer) | Sale | 4,260 | 12.95 | 55,167 |
| 2017-11-02 | Mcdowell Caryn Gordon (GC & Chief Compliance Officer) | Option Ex | 1,355 | 6.57 | 8,902 |
| 2017-11-01 | Malik Fady Ibraham (EVP Research & Development) | Sale | 7,321 | 13.38 | 97,918 |
| 2017-11-01 | Malik Fady Ibraham (EVP Research & Development) | Option Ex | 6,666 | 11.10 | 73,992 |
| 2017-11-01 | Blum Robert I (President & CEO) | Sale | 5,000 | 13.51 | 67,530 |
| 2017-10-06 | Mcdowell Caryn Gordon (GC & Chief Compliance Officer) | Sale | 13,181 | 15.53 | 204,727 |
| 2017-10-06 | Mcdowell Caryn Gordon (GC & Chief Compliance Officer) | Option Ex | 11,583 | 6.57 | 76,100 |
| 2017-10-02 | Blum Robert I (President & CEO) | Sale | 5,000 | 14.55 | 72,770 |
| 2017-10-02 | Gage L Patrick (Director) | Sale | 5,000 | 14.55 | 72,770 |
| 2017-10-02 | Gage L Patrick (Director) | Option Ex | 5,000 | 4.02 | 20,099 |
| 2017-09-06 | Mcdowell Caryn Gordon (GC & Chief Compliance Officer) | Sale | 10,231 | 14.78 | 148,966 |
| 2017-09-06 | Mcdowell Caryn Gordon (GC & Chief Compliance Officer) | Option Ex | 10,231 | 6.57 | 67,217 |
| 2017-09-01 | Blum Robert I (President & CEO) | Sale | 5,000 | 14.75 | 73,750 |
| 2017-09-01 | Gage L Patrick (Director) | Sale | 5,000 | 14.73 | 73,655 |
| 2017-09-01 | Gage L Patrick (Director) | Option Ex | 5,000 | 4.02 | 20,099 |
| 2017-08-31 | Morgan Bradley Paul (SVP Drug Discovery & Early Dev) | Sale | 118,330 | 15.00 | 1,774,950 |
| 2017-08-31 | Morgan Bradley Paul (SVP Drug Discovery & Early Dev) | Option Ex | 118,330 | 8.65 | 1,023,436 |
| 2017-08-31 | Costa Santo J (Director) | Sale | 5,000 | 15.00 | 75,000 |
| 2017-08-31 | Costa Santo J (Director) | Option Ex | 5,000 | 4.44 | 22,200 |
| 2017-08-29 | Gage L Patrick (Director) | Sale | 5,000 | 14.00 | 70,000 |
| 2017-08-29 | Gage L Patrick (Director) | Option Ex | 5,000 | 4.02 | 20,099 |
| 2017-08-29 | Costa Santo J (Director) | Sale | 5,000 | 14.00 | 70,000 |
| 2017-08-29 | Costa Santo J (Director) | Option Ex | 5,000 | 4.44 | 22,200 |
| 2017-08-08 | Mcdowell Caryn Gordon (GC & Chief Compliance Officer) | Sale | 11,348 | 12.51 | 141,963 |
| 2017-08-08 | Mcdowell Caryn Gordon (GC & Chief Compliance Officer) | Option Ex | 9,538 | 6.57 | 62,664 |
| 2017-08-01 | Blum Robert I (President & CEO) | Sale | 5,000 | 13.78 | 68,905 |
| 2017-07-03 | Blum Robert I (President & CEO) | Sale | 5,000 | 12.16 | 60,780 |
| 2017-06-01 | Blum Robert I (President & CEO) | Sale | 5,000 | 13.62 | 68,125 |
| 2016-12-29 | Malik Fady Ibraham (EVP Research & Development) | Sale | 1,326 | 12.52 | 16,600 |
| 2016-12-28 | Malik Fady Ibraham (EVP Research & Development) | Sale | 4,307 | 12.31 | 53,032 |
| 2015-08-31 | Gage L Patrick (Director) | Buy | 1,000 | 6.95 | 6,950 |
| 2015-08-20 | Gage L Patrick (Director) | Buy | 10,000 | 6.51 | 65,100 |
| 2015-05-06 | Gage L Patrick (Director) | Buy | 10,000 | 5.71 | 57,070 |
| 2015-03-11 | Wolff Andrew A (SVP & CMO) | Sale | 21,875 | 7.81 | 170,843 |
| 2015-03-11 | Wolff Andrew A (SVP & CMO) | Option Ex | 21,875 | 6.30 | 137,812 |
Insider trading activities including stock purchases, stock sales, and option exercises of CYTK listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Cytokinetics Inc (symbol CYTK, CIK number 1061983) see the Securities and Exchange Commission (SEC) website.